Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trialArta M. Monjazeb, Karen Kelly, Alexander D. Borowsky et al.|Nature Communications|2023Cited by 21
Atezolizumab plus stereotactic ablative therapy for medically inoperable patients with early-stage non-small cell lung cancer.Karen Kelly, Arta M. Monjazeb, Megan E. Daly et al.|Journal of Clinical Oncology|2020Cited by 12
Presentation at computed tomography (CT) scan of the thorax and first year diagnostic and treatment utilization among patients diagnosed with lung cancerAdam C. Powell, Amit Gupta, Bryan A. Loy et al.|PLoS ONE|2017Cited by 3